Home > Financial Ratios > CORAL LABORATORIES

CORAL LABORATORIES
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

CORAL LABORATORIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 54.55113.62-17.82-33.6073.39

What is the latest Core EBITDA Growth ratio of CORAL LABORATORIES ?

The latest Core EBITDA Growth ratio of CORAL LABORATORIES is 54.55 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202554.55
Mar2024113.62
Mar2023-17.82
Mar2022-33.60
Mar202173.39

How is Core EBITDA Growth of CORAL LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 54.55
-51.99
Mar2024 113.62
Positive
Mar2023 -17.82
Negative
Mar2022 -33.6
Negative
Mar2021 73.39 -

Other Financial Ratios of CORAL LABORATORIES


Compare Core EBITDA Growth ratio of peers of CORAL LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORAL LABORATORIES ₹139.4 Cr -9.4% -9.5% -46.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,555.0 Cr -1.5% 1.6% 1.3% Stock Analytics
DIVIS LABORATORIES ₹159,889.0 Cr -2% -4.3% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,073.0 Cr -0.8% 0.5% 32% Stock Analytics
DR REDDYS LABORATORIES ₹105,133.0 Cr -2.7% -1.6% 6.9% Stock Analytics
CIPLA ₹98,492.9 Cr -3.9% -9.1% -18.4% Stock Analytics


CORAL LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORAL LABORATORIES

-9.4%

-9.5%

-46.6%

SENSEX

-2.6%

-10.2%

-1.6%


You may also like the below Video Courses